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Abstract We have investigated the functional properties of a
mutant (Cg1) derived from the C-terminal 99 amino acids of
chicken caldesmon, 658^756 (658C) where the sequence 691glu-
trp-leu-thr-lys-thr696 is changed to pro-gly-his-tyr-asn-asn. Cg1
bound Ca2+-calmodulin with (1/7)th of the affinity as compared
to 658C or whole caldesmon. NMR titrations indicate that the
contacts of Ca2+-calmodulin with the Trp-722 region of the
peptide are retained but that those at the mutated site are lost.
Most importantly Ca2+-calmodulin is not able to reverse the
Cg1-induced inhibition. We conclude that the interaction of
calmodulin with this caldesmon sequence is crucial for the
reversal of caldesmon inhibition of actin-tropomyosin activation
of myosin ATPase. The results are interpreted in terms of multi-
site attachment of actin and Ca2+-calmodulin to overlapping
sequences in caldesmon domain 4b.
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1. Introduction
Caldesmon is a component of the thin ¢laments of smooth
muscles [1]. In vitro caldesmon binds to actin and inhibits
actin-tropomyosin ¢lament activity in a manner analogous
to troponin-I [2^4]. The inhibition is released by EF hand
Ca2 binding proteins such as calmodulin, troponin-C and
S100 [5^7]. The mechanism of this switch is based on the
binding of caldesmon with both actin and Ca2-calmodulin
[5,8]. Binding sites for both proteins are contained within the
C-terminal 170 residues of caldesmon [9,10]. Analysis of var-
ious peptides, substitution mutants and deletion mutants of
the C-terminus of caldesmon has shown that binding involves
several discrete and separate sequences for actin as well as for
calmodulin (reviewed in [11]). The C-terminal 99 residues of
caldesmon (chicken sequence 658^756) have received particu-
lar attention since this peptide contains multiple actin and
Ca2-calmodulin binding regions and retains the inhibitory
and regulatory properties of the whole molecule [10,12,13].
There is an emerging consensus that Ca2-calmodu-
lin binds to caldesmon through three short, tryptophan-con-
taining, sequences which we have designated as sites A,
B and BP (658MWEKGNVFS666, 687SRINEWLTK695 and
717GKRNLWEKQ725 respectively). Various studies have
aimed to determine the role of each of the three trypto-
phan-containing sequences of caldesmon in Ca2-calmodulin
binding and the consequent release of ATPase but the data
are not conclusive and sometimes contradictory [13^17].
In previous work we have analysed Ca2-calmodulin bind-
ing to caldesmon in combination with structural analysis us-
ing NMR spectroscopy and measurements of caldesmon reg-
ulatory function with a range of caldesmon and calmodulin
mutant peptides [13,14,18]. We have interpreted these results
in terms of multiple contacts between Ca2-calmodulin and
the caldesmon C-terminus involving the interaction of site B
with the C-terminal domain of calmodulin and site A and BP
with the N-terminal part of calmodulin. We also proposed
that at least two contact sites are needed for Ca2-calmodulin
binding to be able to reverse inhibition. In order to test this
model we have constructed and characterised a mutant of the
C-terminal 99 amino acids of caldesmon (658C) in which only
one of the three putative Ca2-calmodulin contact sites re-
mains intact (BP). In this mutant (which we call Cg1) we
changed the sequence 691glu-trp-leu-thr-lys-thr696 (site B) to
pro-gly-his-tyr-asn-asn. We found that the mutation in Cg1
reduced the a⁄nity for Ca2-calmodulin 7-fold and com-
pletely abolished the ability of Ca2-calmodulin to reverse
the inhibition of the actin-tropomyosin activation of myosin
ATPase, whereas interactions with actin were not greatly af-
fected. This demonstrates the importance of site B in the
release of 658C-induced inhibition and con¢rms the necessity
for multi-point attachment between Ca2-calmodulin and cal-
desmon for reversal of inhibition.
2. Materials and methods
2.1. Proteins
Bovine brain calmodulin, rabbit skeletal muscle myosin subfrag-
ment-1 and actin and sheep or gizzard smooth muscle caldesmon
and tropomyosin were prepared by our established methods [14,19].
Wheat germ calmodulin was prepared, puri¢ed and spin-labelled at
Cys-27 as previously reported [20]. The C-terminal caldesmon mutant
peptide 658C (chicken caldesmon h residues 658^756) was obtained by
bacterial expression in the pMW172 plasmid/BL21(DE3) cell system
and puri¢ed as described by Redwood and Marston [10]. The mutant
plasmid for Cg1 was produced by the inverse PCR method [21] using
the expression plasmid pMW172 encoding 658C [22]. Two back-to-
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back primers, 5P-CCTGCTCCAAAACCTTCTGAT-3P and 5P-CGA-
TTTGTTACCCTCTGGGTTGTTGTAATGCCCTGGGTTGATA-
CGACTGGAGAC-3P (altered nucleotides underlined) were used to
change 691glu-trp-leu-thr-lys-thr696 to pro-gly-his-tyr-asn-asn. The
yield of 658C and Cg1 was 15^20 mg pure protein per litre expression
medium. On SDS-PAGE they migrated with identical apparent mo-
lecular weights of 10 500 Da. Protein concentrations were determined
by the method of Lowry et al. [23].
2.2. Assays
Binding of 658C and Cg1 to Ca2-calmodulin was measured di-
rectly by cosedimentation of caldesmon peptides, 658C and Cg1,
with Ca2-calmodulin coupled to Sepharose (Pharmacia) as described
in [14,19]. Fluorescence spectra of 658C and Cg1 were recorded on a
Perkin Elmer luminescence spectrometer (LS-5) with excitation at 295
nm; titrations with calmodulin were performed according to the pro-
cedure described by Huber et al. [14]. The e¡ect of 658C and Cg1 on
actin-tropomyosin activated myosin MgATPase activity was measured
by our usual protocols [14,19].
2.3. Nuclear magnetic resonance (NMR) measurements
One-dimensional proton NMR spectra were obtained at 500 mHz
on a Bruker AMX spectrometer using quadrature detection at a sam-
ple temperature of 25‡C in D2O solution. The binding titrations were
carried out by addition of small aliquots of a concentrated stock
solution of spin-labelled calmodulin as previously described [14] keep-
ing dilution e¡ects below 5%.
3. Results and discussion
The regulatory function of caldesmon in smooth muscle
thin ¢laments consists of its tropomyosin-dependent inhibi-
tory activity and a release mechanism, mediated by a Ca2
binding protein such as calmodulin, by which caldesmon’s
interaction with actin-tropomyosin is altered to allow for my-
osin ATPase activation [11].
The 658C recombinant peptide of chicken gizzard caldes-
mon (residues 658^756), including a point mutation Trp-
659CGly (Ca2-calmodulin binding site A) retains binding
to actin and to Ca2-calmodulin. Its tropomyosin-dependent
inhibitory activity can be fully released upon interaction with
Ca2-calmodulin like that of native caldesmon [4,10]. Nuclear
magnetic resonance spectra have demonstrated that the inter-
action of this peptide with Ca2-calmodulin involves both
tryptophan residues at positions 692 and 722 [14]. The Cg1
mutation (691glu-trp-leu-thr-lys-thr696 to pro-gly-his-tyr-asn-
asn) included the replacement of the hydrophobic residue
tryptophan 692 by glycine, charge changes (lyss asn), the
introduction of two unique residues, histidine and tyrosine,
to aid NMR characterisation and a proline residue aiming
to a¡ect binding of Ca2-calmodulin to this site by a¡ecting
the ability of this sequence to adopt a helical conforma-
tion.
3.1. Binding of the caldesmon mutants to Ca2+-calmodulin
Binding of 658C and Cg1 to calmodulin was measured by
the established techniques of cosedimentation with calmodu-
lin-Sepharose and tryptophan £uorescence titrations
[13,14,16]. Both 658C and Cg1 cosedimented with calmodulin
bound to Sepharose in the presence of Ca2 (Fig. 1A). Bind-
ing was speci¢c since control caldesmon peptides (e.g. N128,
H10, [10,24]) not containing the Ca2-calmodulin binding se-
quences did not cosediment in the presence of Ca2 and none
of the peptides cosedimented in EGTA bu¡er (pCa9) (data
not shown). The dissociation constants derived from ¢ve sep-
arate assays were for 658C: Kd = 1.9 þ 1.1 WM (n = 5) and for
Cg1: Kd = 14.1 þ 6.9 WM (n = 5), thus the a⁄nity of Cg1 is
approximately 1/7 of the a⁄nity of 658C. In previous work
the a⁄nity of 658C for Ca2-calmodulin was found to be
indistinguishable from the whole caldesmon molecule [13]
when measured by three di¡erent methods, thus the mutation
in Cg1 induces a speci¢c reduction in Ca2-calmodulin a⁄n-
ity. Graether et al. noted a similar, 3-fold, decrease in a⁄nity
for Ca2-calmodulin due to mutation of Trp-692 [16].
The reduced a⁄nity of Cg1 compared with 658C was con-
¢rmed in £uorescence titrations with Ca2-calmodulin. The
£uorescence measurements suggested that both tryptophan
residues in 658C, Trp-692 and Trp-722, contribute equally
to the £uorescence intensity since the £uorescence of Cg1
was half of that measured for an equal concentration of
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Fig. 1. Binding of Cg1 or 658C to Ca2-calmodulin. A: Increasing
concentrations of Cg1 or 658C were cosedimented with calmodulin
coupled to Sepharose (Pharmacia). Conditions: 10 mM KCl, 5 mM
PIPES adjusted to pH 7.2 with KOH solution at 22‡C, 2.5 mM
MgCl2, 0.5 mM DTT and 0.1 mM CaCl2 or 0.5 mM EGTA, 22‡C.
A simple binding curve was ¢tted through the data and dissociation
constants calculated for a single binding site: 658C: Kd = 1.9 þ 1.1
WM (n = 5) and for Cg1: Kd = 14.1 þ 6.9 WM (n = 5). Symbols: (b)
Cg1; (O) 658C. Bars represent standard errors of data pooled from
three experiments. B, C: E¡ect of Ca2-calmodulin on the trypto-
phan £uorescence emission of the caldesmon peptides Cg1 and
658C. Conditions were: 50 mM NaCl, 10 mM Tris-HCl, pH 7.2,
2.5 mM MgCl2 and 0.1 mM CaCl2 or 0.5 mM EGTA, 5 WM 658C
or Cg1. B: The blue shift of the spectrum maximum. Dissociation
constants were calculated on the basis of the equation Kd = concen-
tration of free calmodulin at 50% change = (calmodulin added)
30.5U(658C or Cg1). 50% changes are indicated by arrows. C: The
emission intensity of the tryptophan £uorescence measured at the
maximum of the spectrum. Data are expressed as the ratio of the
change in £uorescence intensities of the caldesmon peptide induced
by Ca2-calmodulin to the £uorescence intensities of Cg1 or 658C
alone. Smooth lines were drawn through the data points. Symbols
are used as in A.
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658C. Upon complex formation with Ca2-calmodulin the
intrinsic tryptophan £uorescence of both caldesmon peptides
increased and the spectral maximum showed a distinct blue
shift (Fig. 1B, C). The change in maximum £uorescence (vF/
F0) with Cg1 was very much less than with 658C, indicating
that the major change in £uorescence upon Ca2-calmodulin
binding to 658C arises from Trp-692 [14]. The maximal blue
shift caused by Ca2-calmodulin in Cg1, 16 nm, was similar to
the maximal shift with 658C, 18 nm. The blue shift was su⁄-
ciently large to estimate a Kd of 2 WM for 658C and 13.5 WM
for Cg1 assuming a linear relationship between binding and
blue shift. This result is thus very similar to that obtained by
cosedimentation.
3.2. NMR titration of 658C and Cg1 with Ca2+-calmodulin
Precise information about caldesmon-calmodulin contacts
can be obtained by nuclear magnetic resonance spectroscopy
once individual resonances have been correlated with speci¢c
groups [25]. 1-D NMR spectra were recorded of 120 WM 658C
and Cg1 titrated with Ca2-calmodulin. In the aromatic re-
gion of the spectrum, presented in Fig. 2, peaks arising from
tryptophan, phenylalanine, tyrosine, and histidine are distinct.
The doublet signals at 7.64 and 7.60 in the spectrum of 658C
have been assigned to the C4H signal resonances of trypto-
phans 692 and 722 respectively [14,25] and it is clear that only
the signal at 7.60 is present in Cg1, thus con¢rming its assign-
ment to Trp-722. Upon titration with spin-labelled Ca2-
calmodulin distinct broadening of the signals of both trypto-
phan residues of 658C indicated their combined involvement
in the interaction with Ca2-calmodulin. Only the tryptophan
signals showed this change; the phenylalanine signals (from
Phe-665 and Phe-752, near the N- and C-termini of the pep-
tide) remained una¡ected by Ca2-calmodulin. The line
broadening occurred progressively during titration and is in-
dicative of fast-intermediate chemical exchange between free
and bound forms of the peptide on the NMR timescale. The
spectral e¡ect of complex formation at any fraction bound is
a sensitive function of the correlation time in the bound com-
plex [26]. Hence the marked e¡ect of substoichiometric Ca2-
calmodulin on the tryptophan signals is a direct indication of
close contact with between 658C and Ca2-calmodulin involv-
ing residues in the region of 692 and 722.
Titration of Cg1 with Ca2-calmodulin again showed spe-
ci¢c broadening in the signals at 7.6 ppm (4H) and 7.45 ppm
(7H) originating from the sole tryptophan at position 722 but
these spectral changes required the addition of higher molar
ratios of Ca2-calmodulin to caldesmon peptide indicating
weaker interaction of Cg1 in accord with the direct binding
experiments (Fig. 1). Hardly any change was detectable for
the signals of the aromatic residues His-693 (7.72 ppm) or
Tyr-694 (6.8 ppm) which had been introduced into Cg1 in
place of the native site B. The data therefore indicate that
the altered site B did not participate in the interaction of
Cg1 with Ca2-calmodulin, while binding still occurred, albeit
somewhat weaker, in the region of Trp-722 corresponding to
site BP.
3.3. Reversal of ATPase inhibition
The mutation in Cg1 caused a 3-fold decreased ability to
inhibit the actin-tropomyosin activated myosin MgATPase as
demonstrated by higher concentrations of Cg1, compared to
658C, which were needed to achieve comparable levels of in-
hibition (Fig. 3; [27]). Ca2-calmodulin reversed the inhibition
caused by 658C as expected but no reversal of the inhibition
due to Cg1 was observed, even at very high Ca2-calmodulin
concentrations (Fig. 3). Sedimentation analysis indicated that
under these conditions Ca2-calmodulin displaced most of the
658C from actin-tropomyosin when bound. In contrast Ca2-
calmodulin did not displace Cg1 from actin-tropomyosin. The
lack of release of Cg1 inhibition by Ca2-calmodulin is thus
largely due to its inability to compete with actin for binding to
Cg1. This correlates with the complete loss of interaction be-
tween Cg1 and Ca2-calmodulin at site B whilst interaction
with actin is retained.
Data from this and other laboratories have shown that
deletion (or replacement) of tryptophan at any one of the
three Ca2-calmodulin binding sequences had very little e¡ect
on the ability of Ca2-calmodulin to regulate the caldesmon-
actin interaction [13,14,18]. Cg1 is the ¢rst inhibitory caldes-
mon peptide retaining only one intact Ca2-calmodulin bind-
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Fig. 2. Binding of 658C and Cg1 to calmodulin monitored by NMR spectroscopy. The aromatic spectral regions are shown: A: 658C: 1, 120
WM 658C; 2, 120 WM 658C+3 WM Ca2-calmodulin; 3, 120 WM 658C+7 WM Ca2-calmodulin. B: Cg1: 1, 160 WM Cg1; 2, 160 WM Cg1+7
WM Ca2-calmodulin; 3, 160 WM Cg1+27 WM Ca2-calmodulin.
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ing site (site BP) which has been tested for functional interac-
tion with Ca2-calmodulin. The absence of functional inter-
action indicates that multi-point attachment is likely to be a
prerequisite for Ca2-calmodulin reversal of caldesmon inhib-
ition.
3.4. Structural basis of Ca2+-calmodulin control of caldesmon
inhibition
In our recent work we have discussed the evidence that
caldesmon inhibition of actin-tropomyosin ¢lament activity
is due to simultaneous binding of several discrete segments
of caldesmon to actin and that the segments connecting these
sequences contribute to positioning the actin binding sequen-
ces to form an inhibitory complex [11,19]. In 658C there are
two actin binding sequences which overlap sites B and BP
respectively. The binding of Ca2-calmodulin at these two
sites seems to be a prerequisite for inhibition reversal in this
C-terminal peptide. Mabuchi et al. [28] have reported an ex-
tended structure of calmodulin in its interaction with caldes-
mon similar to the complex of troponin-I with troponin-C
[29,30]. Our data suggest that an extended Ca2-calmodulin
makes contacts on sites B and BP of 658C inducing alteration
of the caldesmon peptide-actin conformation accompanied by
a weakening of actin-caldesmon binding which may result in
dissociation and which results in release of the inhibition.
The change of sequence at site B in Cg1 reduces the a⁄nity
of this site for actin slightly but has a much greater e¡ect
upon the a⁄nity of site B for Ca2-calmodulin. This may
be related to the observations that, at least in short peptides,
site B has an K-helical conformation when bound to Ca2-
calmodulin [17]. This conformation would be greatly destabi-
lised by the proline inserted at position 691 in Cg1. Both actin
and Ca2-calmodulin contacts with site BP are retained in the
mutant Cg1. As a consequence inhibitory actin binding is
essentially retained in Cg1 whilst the reversal of inhibition
due to Ca2-calmodulin binding is lost.
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